Shares of UnitedHealth Group Incorporated (NYSE:UNH) bought by Lombard Odier Asset Management Europe Ltd

Lombard Odier Asset Management Europe Ltd boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 72.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 68,394 shares of the health care conglomerate’s stock after buying an additional 28,797 shares during the quarter. UnitedHealth Group makes up about 1.6% of Lombard Odier Asset Management Europe Ltd’s investment portfolio, making the stock its 7th biggest holding. Lombard Odier Asset Management Europe Ltd’s holdings in UnitedHealth Group were worth $34,830,000 at the end of the most recent reporting period.

A number of other hedge funds have recently bought and sold shares of the company. Aveo Capital Partners LLC boosted its holdings in shares of UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the medical conglomerate’s stock worth $1,139,000 after acquiring an additional 416 shares during the period. 9258 Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after purchasing an additional 290 shares during the last quarter. Gryphon Financial Partners LLC raised its holdings in shares of UnitedHealth Group by 80.9% in the fourth quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the medical conglomerate’s stock worth $3,275,000 after purchasing an additional 2,782 shares during the last quarter. TrinityPoint Wealth LLC boosted its stake in UnitedHealth Group by 102.8% in the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the medical conglomerate’s stock valued at $7,778,000 after acquiring an additional 7,489 shares in the last quarter. Finally, Hudson Value Partners LLC boosted its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Hudson Value Partners LLC now owns 965 shares of the healthcare conglomerate’s stock valued at $508,000 after purchasing an additional 111 shares in the last quarter. 87.86% of the shares are currently owned by institutional investors and hedge funds.

Changes in Analyst Ratings

A number of research analysts recently weighed in on the stock. Baird RW raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Monday, September 16th. Argus boosted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. HSBC upped their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, TD Cowen boosted their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $614.17.

Check out our latest research report on UNH

Insider buying and selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed via this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC’s website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of shares are owned by corporate insiders.

UnitedHealth Group stock fell 0.4%

NYSE UNH opened at $575.00 on Monday. The company has a market cap of $529.22 billion, a price-to-earnings ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88, and a debt-to-equity ratio of 0.67. The company has a 50-day moving average of $577.10 and a 200-day moving average of $521.14. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94.

UnitedHealth Group (NYSE:UNH – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $6.14 per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16. This represents an annualized dividend of $8.40 and a dividend yield of 1.46%. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Read more

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.